Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- LONDON BRIEFING: Stocks called down ahead of US employment data
23 Jan 2025 - Angle stock surges as firm showcases new assay products
15 Nov 2024 - LONDON MARKET MIDDAY: Stocks turn greener despite "gloomy" government
15 Nov 2024 - AIM WINNERS & LOSERS: Solid State to miss forecasts on order delays
15 Nov 2024 - Angle notes use of Parsortix system in treatment resistance study
11 Nov 2024 - EARNINGS: Ebiquity bemoans poor conditions on swing to interim loss
26 Sep 2024 - IN BRIEF: Angle celebrates agreement with Recursion Pharmaceuticals
19 Sep 2024 - Angle signs new agreement US biotech Recursion
19 Sep 2024
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
LONDON BRIEFING: Stocks called down ahead of US employment data
(Alliance News) - Stocks were called lower in London on Thursday, after a disappointing report on UK consumer confidence.
Angle stock surges as firm showcases new assay products
(Alliance News) - Angle PLC on Friday said it is has presented data that highlights the potential of a new assay for lung cancer patients, and will so...
LONDON MARKET MIDDAY: Stocks turn greener despite "gloomy" government
(Alliance News) - Stock prices in London were mostly higher at midday on Friday, despite disappointing data including weaker-than-expected gross domes...
AIM WINNERS & LOSERS: Solid State to miss forecasts on order delays
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.
Angle notes use of Parsortix system in treatment resistance study
(Alliance News) - Angle PLC on Monday said its in-vitro diagnostic Parsortix system was successfully used in a non-small cell lung cancer study to hel...
EARNINGS: Ebiquity bemoans poor conditions on swing to interim loss
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...
IN BRIEF: Angle celebrates agreement with Recursion Pharmaceuticals
Angle PLC - Guildford, England-based liquid biopsy company - Announces it has signed an agreement with Recursion Pharmaceuticals Inc, a clinical-stage...
Angle signs new agreement US biotech Recursion
(Sharecast News) - Angle's share price received a boost on Thursday after the liquid biopsy company announced a new agreement with Utah-based biotech ...
Follow the stocks
